Supervised Machine-Learning Reveals That Old and Obese People Achieve Low Dapsone Concentrations

Abstract

The human species is becoming increasingly obese. Dapsone, which is extensively used across the globe for dermatological disorders, arachnid bites, and for treatment of several bacterial, fungal, and parasitic diseases, could be affected by obesity. We performed a clinical experiment, using optimal design, in volunteers weighing 44–150 kg, to identify the effect of obesity on dapsone pharmacokinetic parameters based on maximum‐likelihood solution via the expectation‐maximization algorithm. Artificial intelligence‐based multivariate adaptive regression splines were used for covariate selection, and identified weight and/or age as predictors of absorption, systemic clearance, and volume of distribution. These relationships occurred only between certain patient weight and age ranges, delimited by multiple hinges and regions of discontinuity, not identified by standard pharmacometric approaches. Older and obese people have lower drug concentrations after standard dosing, but with complex patterns. Given that efficacy is concentration‐dependent, optimal dapsone doses need to be personalized for obese patients.

Artificial Intelligence and Race: a Systematic Review

“…Another AI study on obesity shows that AI machine learning algorithms are able to examine human biological data including race (between white and non-white people) to find the linkages among elderly people in the US and their low Dapsone (an antibiotic drug) concentrations. The study reports that there is a need to redefine doses of Dapsone for obese and aged patients (Hall, Pasipanodya, Swancutt, Meek, Leff, and Gumbo, 2017). People who are obese are also at risk of high blood pressure.…”

Detectable prednisolone is delayed in pericardial fluid, compared with plasma of patients with tuberculous pericarditis: A pilot study

“…Prednisolone concentrations were modeled using ADAPT 5 (Biomedical Simulations Resource, California, USA) software of D'Argenio et al [17] We used the maximum likelihood expectation maximization algorithm. We modeled the concentrations using a one-compartment and a two-compartment model with first-order input and elimination, as described in our prior publications [[18], [19], [20], [21]]. Akaike information criteria (AIC), Bayesian information criteria (BIC) and parsimony were then used to choose the best number of pharmacokinetic compartments.…”

Restructured society and environment: A review on potential technological strategies to control the COVID-19 pandemic

“…Heinson et al used ML in reverse vaccinology whose purpose is to distinguish the bacterial protective antigens (BPAs) from nonbacterial protective antigens and this would boost the progress of developing vaccines (Heinson et al, 2017). Studies also suggest that AI will assist in the drug development field to analyze the possible outcomes in using a clinical trial drug (Doyle et al, 2015) and also to identify the response in the patient body (Vidyasagar, 2015;Hall et al, 2017). Another problem in the medical field of intensive care is the individual ventilator setting for each patient.…”